BIOMAT Database Logo BIOMAT Database Logo

[Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis]. 1988

B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013949 Thymus Extracts Extracts of the THYMUS GLAND that contain specific factors, peptides, and proteins with specific biological activities. Thymus Extract,Extract, Thymus,Extracts, Thymus

Related Publications

B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Immunological bases of tuberculin therapy in combined treatment of patients with pulmonary tuberculosis].
January 1994, Problemy tuberkuleza,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Combined therapy of experimental tuberculosis with antibacterial preparations and tuberculin].
December 1957, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Tuberculin-BCG therapy in combined treatment of patients with pulmonary tuberculosis].
January 1995, Problemy tuberkuleza,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Treatment of tuberculosis in children and adolescents with antibacterial preparations combined with tuberculin].
January 1974, Problemy tuberkuleza,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Combined use of the Koch tuberculin provocation test and immunological tests in patients with urinary tuberculosis].
January 1995, Problemy tuberkuleza,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[PROPERDIN IN THE BLOOD SERUM OF PATIENTS WITH TUBERCULOSIS DURING THERAPY WITH ANTIBACTERIAL PREPARATIONS AND TUBERCULIN].
January 1964, Voprosy meditsinskoi khimii,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
Combined streptomycin-tuberculin therapy in pulmonary tuberculosis; methods of treatment.
February 1952, United States Armed Forces medical journal,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Treatment with antibacterial preparations and tuberculin of patients with destructive forms of pulmonary tuberculosis].
May 1967, Vrachebnoe delo,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Immunological shifts in pulmonary tuberculosis patients with tuberculin hyposensitization].
June 1980, Problemy tuberkuleza,
B E Knoring, and A V Vasil'ev, and I Ia Sakharova, and N A Machkova, and L A Ivanova
[Effectiveness of tuberculin in the combined treatment of pulmonary tuberculosis patients].
January 1985, Problemy tuberkuleza,
Copied contents to your clipboard!